title: [Diabetic edematous maculopathy associated with rosiglitazone treatment: report of a case].
abstract: A 61-year-old woman is referred for bilateral diabetic macular edema. Her visual acuity is 20/70 in the right eye and 20/50 in the left eye. She presents a macular edema on both eyes. Her diabetes and her blood pressure are well controlled. We note that the decrease in visual acuity occured when the patient began taking rosiglitazone (Avandia) 4 mg per day. Three months after replacing rosiglitazone by gliclazide (Diamicron), the visual acuity of the patient improves to 20/40 in the right eye and 20/30 in the left eye.
authors.affiliation: Cliniques Universitaires Saint Luc, UCL, Brussels. valentinenyssen@yahoo.fr
authors.forename: V
authors.initials: V
authors.lastname: Nyssen
authors.forename: F
authors.initials: F
authors.lastname: Hautenauven
authors.forename: J P
authors.initials: JP
authors.lastname: Lekeu Hinostroza
authors.forename: A P
authors.initials: AP
authors.lastname: Guagnini
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D003930:Diabetic Retinopathy / Q000139:chemically induced* / Q000150:complications; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008269:Macular Edema / Q000139:chemically induced* / Q000150:complications; D008875:Middle Aged; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone